Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Xingwen Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Gastrointestinal Microbiome, Diet, High-Fat, Mice, Inbred C57BL. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: General scientific research project of Zhejiang Provincial Department of Education, National Key Research and Development Program of China Stem Cell and Translational Research, Zhoushan Science and Technology Project of China.
Abstract (Originalsprache)
To explore the potential mechanism of action of Tegillarca granosa polysaccharide (TGP) in treating nonalcoholic fatty liver disease (NAFLD), the study conducts in vivo experiments using male C57BL/6 mice fed a high‐fat diet while administering TGP for 16 weeks. The study measures body weight, liver weight, serum biochemical markers, pathological histology, liver lipid accumulation, oxidative stress and inflammation‐related factors, lipid synthesis and metabolism‐related gene and protein expression, and the composition and abundance of intestinal flora. Additionally, short‐chain fatty acid (SCFAs) content and the correlation between intestinal flora and environmental factors are measured. The results show that TGP effectively reduces excessive hepatic lipid accumulation, dyslipidemia, abnormal liver function, and steatosis in the mice with NAFLD. Moreover, TGP effectively regulates intestinal flora disorder, increases the diversity of intestinal flora, and affects the relative abundance of specific bacteria while also increasing the content of SCFAs. These findings provide a basis for exploring the regulatory effect of T. granosa polysaccharide on NAFLD based on intestinal flora and highlight its potential as a natural liver nutraceutical.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Food Science and Technology, Zhejiang University of Technology, Hangzhou, 310014, China.
- Key Laboratory of Marine Fishery Resources Exploitment & Utilization of Zhejiang Province, Hangzhou, 310014, China.
- National R&D Branch Center for Pelagic Aquatic Products Processing (Hangzhou), Hangzhou, 310014, China.
- Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, 310021, China.
ORCID-Profile: Xingwei Xiang
Förderung
- General scientific research project of Zhejiang Provincial Department of Education
- National Key Research and Development Program of China Stem Cell and Translational Research
- Zhoushan Science and Technology Project of China
Zitieren
APA
Yang, X., Yao, S., Jiang, Q., Chen, H., Liu, S., Shen, G., Xiang, X., & Chen, L. (2024). Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300453
Vancouver
Yang X, Yao S, Jiang Q, Chen H, Liu S, Shen G, et al. Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300453
BibTeX
@article{Yang2024,
author = {Yang, Xingwen and Yao, Shiwei and Jiang, Qihong and Chen, Hui and Liu, Shulai and Shen, Guoxin and Xiang, Xingwei and Chen, Lin},
title = {Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300453}
}
EUVIMED